Mexico Expands Bioethics Committees to All Levels of Healthcare

The National Bioethics Commission (CONBIOÉTICA) highlighted that the update to the General Health Law expands the scope of ethics committees, incorporating them at all levels of care. Recent amendments to the General Health Law on bioethics consolidated a new framework for medical practice in Mexico, by expanding the operation of ethics committees and strengthening the protection of individuals in health services, reported the National Bioethics Commission (CONBIOÉTICA). The head of the institution, Patricio Javier Santillán Doherty, stated that this reform allowed for the reinforcement of clinical decision-making based on fundamental principles such as autonomy, beneficence, non-maleficence, and justice, integrating bioethics as a cross-cutting axis of the health system. Expansion of bioethics to all levels of care. One of the central changes was the transformation of Hospital Bioethics Committees into Bioethics Committees for Health Care (CBAS), which expanded their scope beyond the hospital setting. This modification allowed for the incorporation of ethical deliberation in primary care, home-based programs, and various care contexts, strengthening comprehensive support in clinical decision-making. Patricio Santillán explained that these committees facilitate ethical analysis in complex scenarios, such as care for early childhood, older adults, patients in palliative care, and people with limited mobility. Ethical principles in daily clinical practice. The new model established that every decision in health must align with fundamental ethical principles, ensuring that medical care is provided with respect for human dignity. The CBAS were consolidated as spaces for deliberation that allow addressing clinical dilemmas from an integral perspective, incorporating medical, social, and human factors in decision-making. Health research with greater ethical and scientific rigor. The reform also strengthened the evaluation of health research by consolidating the Ethics and Research Committees, responsible for reviewing protocols under scientific and bioethical criteria. According to the information presented, in 2024 these committees analyzed 17,000 protocols at the national level, which reflects the magnitude of the health research system and the importance of its ethical supervision. Biosafety and control of health risks. Another relevant component was the participation of the Biosafety Committee, which ensured the proper handling of substances, radiation, and biological agents in health establishments. This approach allowed for the reinforcement of safety in clinical and research processes, minimizing risks for patients, healthcare personnel, and the community. National infrastructure in bioethics. Currently, the country has approximately 1,200 hospital bioethics committees and 350 ethics and research committees registered with CONBIOÉTICA, which evidences the consolidation of an institutional network aimed at promoting ethics in health care. This system has contributed to strengthening a bioethics culture focused on the protection of human dignity, as well as the continuous improvement of health services. Towards an integral ethical approach in health care. The reform positioned bioethics as an essential component in medical practice, by integrating ethical criteria at all levels of the health system. Santillán Doherty emphasized that these changes seek to ensure that every medical intervention is based not only on scientific evidence but also on ethical principles that protect individuals.